Fairfield, Bush & Co. Lantheus Holdings, Inc. Transaction History

Fairfield, Bush & Co.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$58.87 - $83.05 $172,489 - $243,336	2,930 New	2,930 $235 Million
Q4 2023 Feb 13, 2024	BUY	$55.6 - $77.89 $96,188 - $134,749	1,730 New	1,730 $107 Million
Q2 2023 Aug 15, 2023	BUY	$82.41 - $99.65 $142,569 - $172,394	1,730 New	1,730 $145 Million
Q2 2022 Aug 09, 2022	SELL	$55.54 - $72.65 $14,995 - $19,615	-270 Reduced 8.44%	2,930 $193,000
Q1 2022 May 06, 2022	BUY	$24.28 - $56.64 $77,696 - $181,248	3,200 New	3,200 $177,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.